| answer text |
<p>In May 2018, the Government announced a £40 million investment over five years
for brain tumour research as part of the Tessa Jowell Brain Cancer Mission through
the National Institute for Health Research (NIHR). Since then, the NIHR has received
69 applications for research funding in <strong>relation </strong>to brain tumours,
with 10 applications funded and seven applications under consideration. All applications
that are fundable have been funded.</p><p>We anticipate that the use of 5-aminolevulinic
acid will increase which will benefit brain tumour patients. This is a brain cancer
treatment used to assist surgeons to differentiate between tumour and normal brain
tissue, increasing the amount of tumour resected during surgery.</p>
|
 |
